US Stock MarketDetailed Quotes
PASG Passage Bio
- 0.751
- +0.130+20.93%
Close Nov 26 16:00 ET
- 0.761
- +0.010+1.33%
Pre 07:00 ET
46.39MMarket Cap-641P/E (TTM)
0.790High0.630Low753.99KVolume0.633Open0.621Pre Close537.67KTurnover1.66%Turnover RatioLossP/E (Static)61.77MShares1.79052wk High0.64P/B34.20MFloat Cap0.45152wk Low--Dividend TTM45.54MShs Float38.230Historical High--Div YieldTTM25.73%Amplitude0.451Historical Low0.713Avg Price1Lot Size
About Passage Bio Company
Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company assembles a portfolio of genetic medicine products, which includes PBGM01 for the treatment of GM1, PBFT02 for the treatment of FTD and PBKR03 for the treatment of Krabbe disease. Passage Bio was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.
Company Profile
SymbolPASG
Company NamePassage Bio
Listing DateFeb 28, 2020
Issue Price18.00
Founded2017
CEODr. William Chou, M.D.
MarketNASDAQ
Employees58
Fiscal Year Ends12-31
AddressOne Commerce Square,2005 Market Street,39th floor
CityPhiladelphia
ProvincePennsylvania
CountryUnited States of America
Zip Code19103
Phone1-267-866-0311
Websitehttp://www.passagebio.com
Company Executives
- Name
- Position
- Salary
- Dr. William Chou, M.D.
- President, Chief Executive Officer and Director
- 1.45M
- Kathleen Borthwick
- Senior Vice President, Principal Accounting Officer and Chief Financial Officer
- --
- Dr. Susan Browne, PhD
- Chief Scientific Officer
- --
- Stuart Henderson
- Chief Business Officer
- --
- Thomas R. Kassberg
- Director
- --
- Sandip S. Kapadia, C.P.A.,M.B.A.
- Independent Director
- 73.34K
- Saqib Islam, J.D.
- Independent Director
- 65.84K
- Dr. Dolan Sondhi, PhD
- Independent Director
- 49.90K
- Dr. Derrell D. Porter, M.D.
- Independent Director
- 69.30K
- Dr. Athena Countouriotis, M.D.
- Independent Director
- 69.97K
- Edgar B. Cale
- General Counsel and Corporate Secretary
- 949.73K
- Dr. Maxine Gowen,PhD
- Chairwoman of the Board
- 101.34K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
